| Primary |
| Dry Eye |
14.7% |
| Postoperative Care |
9.8% |
| Off Label Use |
9.5% |
| Eye Inflammation |
8.8% |
| Keratoconjunctivitis Sicca |
8.5% |
| Blepharitis |
5.2% |
| Vitamin Supplementation |
4.6% |
| Product Used For Unknown Indication |
3.9% |
| Drug Use For Unknown Indication |
3.6% |
| Eye Irritation |
3.6% |
| Keratitis |
3.6% |
| Ocular Hyperaemia |
3.6% |
| Conjunctivitis Allergic |
3.3% |
| Hypertension |
3.3% |
| Glaucoma |
2.9% |
| Depression |
2.6% |
| Conjunctivitis |
2.3% |
| Eye Infection |
2.3% |
| Corneal Infiltrates |
2.0% |
| Eye Allergy |
2.0% |
|
| Visual Acuity Reduced |
12.5% |
| Drug Ineffective |
11.5% |
| Vision Blurred |
10.4% |
| Eye Irritation |
8.3% |
| Hypersensitivity |
6.3% |
| Headache |
5.2% |
| Intraocular Pressure Increased |
5.2% |
| Condition Aggravated |
4.2% |
| Foreign Body Sensation In Eyes |
4.2% |
| Nausea |
4.2% |
| Toothache |
4.2% |
| Visual Impairment |
4.2% |
| Dizziness |
3.1% |
| Ocular Hyperaemia |
3.1% |
| Weight Decreased |
3.1% |
| Blepharospasm |
2.1% |
| Blood Glucose Increased |
2.1% |
| Drug Effect Decreased |
2.1% |
| Drug Hypersensitivity |
2.1% |
| Dyspnoea |
2.1% |
|
| Secondary |
| Off Label Use |
12.2% |
| Postoperative Care |
10.3% |
| Dry Eye |
9.9% |
| Hypertension |
8.2% |
| Eye Inflammation |
7.9% |
| Keratitis |
6.1% |
| Blepharitis |
5.8% |
| Corneal Infiltrates |
5.6% |
| Product Used For Unknown Indication |
3.7% |
| Cardiac Disorder |
3.5% |
| Keratoconjunctivitis Sicca |
3.5% |
| Vitamin Supplementation |
3.3% |
| Post Procedural Complication |
3.1% |
| Eye Injury |
2.8% |
| Preoperative Care |
2.6% |
| Blood Cholesterol Increased |
2.4% |
| Depression |
2.3% |
| Glaucoma |
2.3% |
| Intraocular Pressure Increased |
2.3% |
| Ocular Hyperaemia |
2.3% |
|
| Visual Acuity Reduced |
25.2% |
| Drug Ineffective |
8.6% |
| Vision Blurred |
7.4% |
| Weight Decreased |
6.7% |
| Intraocular Pressure Increased |
5.5% |
| Keratoconjunctivitis Sicca |
5.5% |
| Mydriasis |
5.5% |
| Toothache |
5.5% |
| Eye Irritation |
4.3% |
| Toxic Anterior Segment Syndrome |
3.7% |
| Off Label Use |
3.1% |
| Condition Aggravated |
2.5% |
| Foreign Body Sensation In Eyes |
2.5% |
| Impaired Healing |
2.5% |
| Vitreous Floaters |
2.5% |
| Diabetes Mellitus |
1.8% |
| Diplopia |
1.8% |
| Eye Swelling |
1.8% |
| Open Angle Glaucoma |
1.8% |
| Suicide Attempt |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.6% |
| Drug Use For Unknown Indication |
16.7% |
| Dry Eye |
10.9% |
| Glaucoma |
4.3% |
| Immunodeficiency Common Variable |
3.8% |
| Rheumatoid Arthritis |
2.9% |
| Crohn's Disease |
2.6% |
| Anxiety |
2.5% |
| Asthma |
2.5% |
| Postoperative Care |
2.5% |
| Pain |
2.2% |
| Breast Cancer |
1.9% |
| Depression |
1.9% |
| Osteoporosis |
1.8% |
| Rosacea |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hypersensitivity |
1.6% |
| Hypertension |
1.6% |
| Insomnia |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
|
| Vomiting |
15.2% |
| Vision Blurred |
13.0% |
| Eye Irritation |
12.3% |
| Ocular Hyperaemia |
6.5% |
| Impaired Healing |
5.1% |
| Visual Acuity Reduced |
5.1% |
| Psoriasis |
3.6% |
| Rash |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Diarrhoea |
2.9% |
| Drug Ineffective |
2.9% |
| Eye Pain |
2.9% |
| Eyelid Function Disorder |
2.9% |
| Injection Site Pain |
2.9% |
| Lichen Planus |
2.9% |
| Muscle Spasms |
2.9% |
| Product Quality Issue |
2.9% |
| Sepsis |
2.9% |
| Tachycardia |
2.9% |
| Urticaria |
2.9% |
|
| Interacting |
| Anxiety |
50.0% |
| Conjunctivitis |
50.0% |
|
|
